Share Price and Basic Stock Data
Last Updated: January 10, 2026, 4:59 am
| PEG Ratio | -19.27 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gujarat Fluorochemicals Ltd operates within the specialty chemicals sector, focusing on fluorochemicals. The company reported a share price of ₹3,508 and a market capitalization of ₹38,588 Cr. Over the past fiscal year, revenues have exhibited a notable increase, with sales for FY 2023 standing at ₹5,685 Cr, up from ₹3,954 Cr in FY 2022. However, the revenue trajectory showed signs of fluctuation in the recent quarters, with sales declining to ₹947 Cr in September 2023 before rebounding to ₹1,133 Cr in March 2024. The trailing twelve months (TTM) revenue reached ₹4,864 Cr, indicating a degree of stabilization following the earlier decline. This volatility in quarterly sales reflects broader market dynamics and possibly changing demand conditions in the specialty chemicals market, which poses challenges for sustained revenue growth.
Profitability and Efficiency Metrics
Gujarat Fluorochemicals reported a net profit of ₹680 Cr for the year ended March 2025, with an impressive operating profit margin (OPM) of 30% for the same period. However, a closer examination of quarterly performance reveals significant variability, with OPM dropping to 17% in September 2023 before gradually improving to 30% by September 2025. The company’s return on equity (ROE) stood at 8.29%, while return on capital employed (ROCE) was recorded at 9.89%. These figures suggest that while profitability metrics are robust, they are lower than the typical industry standards, which can range significantly higher for leading players in the specialty chemicals sector. Additionally, the company maintained an interest coverage ratio of 8.26x, indicating a solid ability to meet interest obligations, although profitability pressures may warrant closer monitoring.
Balance Sheet Strength and Financial Ratios
Gujarat Fluorochemicals’ balance sheet reflects a relatively conservative leverage position, with total borrowings reported at ₹1,722 Cr against reserves of ₹7,606 Cr. The company’s total assets increased to ₹10,618 Cr by September 2025, supported by a modest debt-to-equity ratio of 0.27, positioning it favorably against industry norms. The price-to-book value (P/BV) ratio stood at 6.09x, indicating a premium valuation relative to its book value of ₹659.93 per share. Furthermore, the current ratio was reported at 1.70, suggesting adequate liquidity to cover short-term obligations. While these metrics indicate a sound financial position, the cash conversion cycle (CCC) of 418 days raises concerns regarding operational efficiency and working capital management. The company’s ability to optimize inventory and receivables management will be crucial for enhancing liquidity and financial flexibility.
Shareholding Pattern and Investor Confidence
The shareholding structure of Gujarat Fluorochemicals indicates a strong promoter presence, with promoters holding 61.39% of the company as of September 2025. This significant ownership can instill confidence among investors regarding the company’s long-term strategic direction. Foreign institutional investors (FIIs) accounted for 4.36% of the shares, while domestic institutional investors (DIIs) held 12.73%. The public shareholding comprised 21.51%, reflecting a healthy distribution of ownership. Notably, the number of shareholders increased to 66,493, suggesting growing retail investor interest. However, the gradual decline in promoter holding from 63.80% in early 2023 to the current level may raise questions about future governance and control. Investors will need to consider these dynamics when assessing the company’s stability and growth prospects.
Outlook, Risks, and Final Insight
Looking ahead, Gujarat Fluorochemicals faces both opportunities and challenges. The specialty chemicals sector is poised for growth, driven by increased demand in various end-user industries; however, the company’s recent revenue fluctuations and declining profitability margins pose risks to sustaining growth. The high cash conversion cycle indicates potential inefficiencies in working capital management that could hinder operational performance. Additionally, external factors such as regulatory changes, raw material price volatility, and global economic conditions could impact the company’s financial health. For investors, the current valuation reflects a premium that necessitates careful consideration of these risks. If the company can successfully leverage its strong reserves and improve operational efficiencies, it may enhance profitability and shareholder returns in the long run. Conversely, failure to address these operational challenges may lead to continued volatility in financial performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 374 Cr. | 40.5 | 77.8/40.0 | 23.2 | 20.5 | 0.99 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 28.6 Cr. | 58.2 | 88.8/55.0 | 13.7 | 89.6 | 1.72 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 48.6 Cr. | 715 | 907/600 | 22.4 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,331 Cr. | 73.5 | 111/68.2 | 22.0 | 22.0 | 0.68 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 600 Cr. | 240 | 393/230 | 21.6 | 93.8 | 1.04 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,757.28 Cr | 703.90 | 65.35 | 183.02 | 0.45% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,461 | 1,418 | 1,471 | 1,209 | 947 | 992 | 1,133 | 1,176 | 1,188 | 1,148 | 1,225 | 1,281 | 1,210 |
| Expenses | 926 | 895 | 942 | 861 | 783 | 786 | 895 | 914 | 893 | 854 | 919 | 937 | 846 |
| Operating Profit | 536 | 523 | 529 | 348 | 164 | 206 | 238 | 262 | 295 | 294 | 306 | 344 | 364 |
| OPM % | 37% | 37% | 36% | 29% | 17% | 21% | 21% | 22% | 25% | 26% | 25% | 27% | 30% |
| Other Income | 24 | 21 | 19 | 15 | 13 | 13 | 18 | 9 | 9 | 14 | 26 | 23 | 6 |
| Interest | 23 | 38 | 35 | 28 | 34 | 37 | 34 | 37 | 42 | 42 | 26 | 30 | 33 |
| Depreciation | 57 | 60 | 64 | 66 | 68 | 72 | 81 | 85 | 90 | 91 | 89 | 90 | 91 |
| Profit before tax | 480 | 446 | 449 | 269 | 75 | 110 | 141 | 149 | 172 | 175 | 217 | 247 | 246 |
| Tax % | 26% | 26% | 26% | 25% | 29% | 27% | 28% | 28% | 30% | 28% | 12% | 26% | 27% |
| Net Profit | 357 | 331 | 332 | 201 | 53 | 80 | 101 | 108 | 121 | 126 | 191 | 184 | 179 |
| EPS in Rs | 32.88 | 29.99 | 30.21 | 18.30 | 4.82 | 7.28 | 9.19 | 9.83 | 11.02 | 11.47 | 17.39 | 16.75 | 16.29 |
Last Updated: January 1, 2026, 1:16 pm
Below is a detailed analysis of the quarterly data for Gujarat Fluorochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,210.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,281.00 Cr. (Jun 2025) to 1,210.00 Cr., marking a decrease of 71.00 Cr..
- For Expenses, as of Sep 2025, the value is 846.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 937.00 Cr. (Jun 2025) to 846.00 Cr., marking a decrease of 91.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 364.00 Cr.. The value appears strong and on an upward trend. It has increased from 344.00 Cr. (Jun 2025) to 364.00 Cr., marking an increase of 20.00 Cr..
- For OPM %, as of Sep 2025, the value is 30.00%. The value appears strong and on an upward trend. It has increased from 27.00% (Jun 2025) to 30.00%, marking an increase of 3.00%.
- For Other Income, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Jun 2025) to 6.00 Cr., marking a decrease of 17.00 Cr..
- For Interest, as of Sep 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Jun 2025) to 33.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 91.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.00 Cr. (Jun 2025) to 91.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 246.00 Cr.. The value appears to be declining and may need further review. It has decreased from 247.00 Cr. (Jun 2025) to 246.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Jun 2025) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 179.00 Cr.. The value appears to be declining and may need further review. It has decreased from 184.00 Cr. (Jun 2025) to 179.00 Cr., marking a decrease of 5.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 16.29. The value appears to be declining and may need further review. It has decreased from 16.75 (Jun 2025) to 16.29, marking a decrease of 0.46.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:17 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,851 | 2,729 | 2,606 | 2,650 | 3,954 | 5,685 | 4,281 | 4,737 | 4,864 |
| Expenses | 3,105 | 1,941 | 2,167 | 2,052 | 2,785 | 3,719 | 3,366 | 3,638 | 3,556 |
| Operating Profit | 745 | 788 | 439 | 598 | 1,168 | 1,965 | 915 | 1,100 | 1,308 |
| OPM % | 19% | 29% | 17% | 23% | 30% | 35% | 21% | 23% | 27% |
| Other Income | 112 | 78 | 190 | 199 | 161 | 172 | 100 | 115 | 69 |
| Interest | 279 | 56 | 105 | 113 | 78 | 117 | 133 | 147 | 131 |
| Depreciation | 299 | 164 | 192 | 202 | 205 | 236 | 286 | 355 | 361 |
| Profit before tax | 279 | 645 | 332 | 482 | 1,045 | 1,785 | 595 | 713 | 885 |
| Tax % | 14% | -93% | 43% | 146% | 26% | 26% | 27% | 23% | |
| Net Profit | 240 | 1,246 | 189 | -222 | 776 | 1,323 | 435 | 546 | 680 |
| EPS in Rs | 17.87 | -19.91 | 71.66 | 120.97 | 39.59 | 49.71 | 61.90 | ||
| Dividend Payout % | 15% | 0% | 0% | 0% | 6% | 3% | 8% | 6% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 419.17% | -84.83% | -217.46% | 449.55% | 70.49% | -67.12% | 25.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | -504.00% | -132.63% | 667.01% | -379.06% | -137.61% | 92.64% |
Gujarat Fluorochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 6% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | -11% |
| TTM: | 82% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 0% |
| 1 Year: | -4% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 13% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 5:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:20 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 4,756 | 3,499 | 3,705 | 3,482 | 4,244 | 5,510 | 5,925 | 7,242 | 7,606 |
| Borrowings | 2,000 | 968 | 1,718 | 1,581 | 1,556 | 1,515 | 2,096 | 2,080 | 1,722 |
| Other Liabilities | 2,986 | 441 | 634 | 895 | 1,067 | 1,335 | 1,201 | 1,270 | 1,279 |
| Total Liabilities | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,602 | 10,618 |
| Fixed Assets | 3,813 | 2,305 | 2,414 | 2,367 | 2,514 | 3,111 | 4,264 | 4,285 | 4,263 |
| CWIP | 724 | 229 | 318 | 400 | 680 | 1,158 | 1,128 | 1,568 | 1,806 |
| Investments | 524 | 342 | 259 | 88 | 20 | 1 | 1 | 289 | 56 |
| Other Assets | 4,691 | 2,042 | 3,076 | 3,114 | 3,665 | 4,101 | 3,840 | 4,460 | 4,493 |
| Total Assets | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,602 | 10,618 |
Below is a detailed analysis of the balance sheet data for Gujarat Fluorochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
- For Reserves, as of Sep 2025, the value is 7,606.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,242.00 Cr. (Mar 2025) to 7,606.00 Cr., marking an increase of 364.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,722.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,080.00 Cr. (Mar 2025) to 1,722.00 Cr., marking a decrease of 358.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,279.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,270.00 Cr. (Mar 2025) to 1,279.00 Cr., marking an increase of 9.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 10,618.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,602.00 Cr. (Mar 2025) to 10,618.00 Cr., marking an increase of 16.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4,263.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,285.00 Cr. (Mar 2025) to 4,263.00 Cr., marking a decrease of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,806.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,568.00 Cr. (Mar 2025) to 1,806.00 Cr., marking an increase of 238.00 Cr..
- For Investments, as of Sep 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 289.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 233.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,493.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,460.00 Cr. (Mar 2025) to 4,493.00 Cr., marking an increase of 33.00 Cr..
- For Total Assets, as of Sep 2025, the value is 10,618.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,602.00 Cr. (Mar 2025) to 10,618.00 Cr., marking an increase of 16.00 Cr..
Notably, the Reserves (7,606.00 Cr.) exceed the Borrowings (1,722.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 743.00 | -180.00 | 438.00 | 597.00 | 0.00 | 0.00 | 913.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 184 | 77 | 79 | 92 | 72 | 71 | 72 | 92 |
| Inventory Days | 736 | 351 | 390 | 404 | 314 | 375 | 435 | 487 |
| Days Payable | 471 | 127 | 176 | 159 | 170 | 174 | 144 | 162 |
| Cash Conversion Cycle | 449 | 301 | 293 | 338 | 216 | 272 | 363 | 418 |
| Working Capital Days | 67 | 22 | -0 | 6 | 33 | 62 | 60 | 97 |
| ROCE % | 11% | 9% | 11% | 20% | 30% | 10% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 1,386,604 | 0.52 | 474.7 | N/A | N/A | N/A |
| Motilal Oswal Large and Midcap Fund | 1,079,452 | 2.44 | 369.55 | 1,028,275 | 2025-12-15 05:01:00 | 4.98% |
| DSP Mid Cap Fund | 607,640 | 1.05 | 208.03 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 605,000 | 0.49 | 207.12 | N/A | N/A | N/A |
| Mirae Asset Focused Fund | 588,038 | 2.55 | 201.31 | 556,129 | 2025-12-15 05:01:00 | 5.74% |
| DSP Flexi Cap Fund | 536,826 | 1.49 | 183.78 | 762,208 | 2025-12-08 05:16:26 | -29.57% |
| DSP Large & Mid Cap Fund | 479,317 | 0.95 | 164.09 | N/A | N/A | N/A |
| Axis Small Cap Fund | 464,211 | 0.59 | 158.92 | N/A | N/A | N/A |
| Motilal Oswal ELSS Tax Saver Fund | 400,000 | 3.08 | 136.94 | 430,073 | 2025-12-15 04:04:44 | -6.99% |
| Nippon India Small Cap Fund | 396,772 | 0.2 | 135.83 | 410,584 | 2025-12-15 03:04:08 | -3.36% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 49.70 | 39.60 | 120.44 | 70.63 | -20.17 |
| Diluted EPS (Rs.) | 49.70 | 39.60 | 120.44 | 70.63 | -20.17 |
| Cash EPS (Rs.) | 81.95 | 65.64 | 141.93 | 89.33 | -1.77 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 659.93 | 540.40 | 502.57 | 385.10 | 316.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 659.93 | 540.40 | 502.57 | 385.10 | 316.70 |
| Revenue From Operations / Share (Rs.) | 431.07 | 389.70 | 517.49 | 359.91 | 241.28 |
| PBDIT / Share (Rs.) | 110.52 | 92.33 | 194.59 | 120.99 | 72.55 |
| PBIT / Share (Rs.) | 78.25 | 66.29 | 173.10 | 102.28 | 54.16 |
| PBT / Share (Rs.) | 64.87 | 54.17 | 162.47 | 95.15 | 43.91 |
| Net Profit / Share (Rs.) | 49.68 | 39.60 | 120.44 | 70.63 | -20.17 |
| NP After MI And SOA / Share (Rs.) | 49.69 | 39.60 | 120.97 | 71.66 | -19.91 |
| PBDIT Margin (%) | 25.63 | 23.69 | 37.60 | 33.61 | 30.06 |
| PBIT Margin (%) | 18.15 | 17.01 | 33.45 | 28.41 | 22.44 |
| PBT Margin (%) | 15.04 | 13.90 | 31.39 | 26.43 | 18.19 |
| Net Profit Margin (%) | 11.52 | 10.16 | 23.27 | 19.62 | -8.35 |
| NP After MI And SOA Margin (%) | 11.52 | 10.16 | 23.37 | 19.91 | -8.25 |
| Return on Networth / Equity (%) | 7.52 | 7.32 | 24.06 | 18.49 | -6.26 |
| Return on Capital Employeed (%) | 10.63 | 10.81 | 31.52 | 22.60 | 14.23 |
| Return On Assets (%) | 5.14 | 4.71 | 15.87 | 11.44 | -3.66 |
| Long Term Debt / Equity (X) | 0.05 | 0.06 | 0.03 | 0.10 | 0.11 |
| Total Debt / Equity (X) | 0.27 | 0.33 | 0.26 | 0.36 | 0.40 |
| Asset Turnover Ratio (%) | 0.47 | 0.48 | 0.74 | 0.59 | 0.42 |
| Current Ratio (X) | 1.70 | 1.36 | 1.50 | 1.28 | 1.08 |
| Quick Ratio (X) | 0.97 | 0.73 | 0.86 | 0.78 | 0.59 |
| Inventory Turnover Ratio (X) | 2.79 | 1.52 | 2.61 | 2.28 | 1.73 |
| Dividend Payout Ratio (NP) (%) | 6.03 | 5.05 | 3.30 | 2.79 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3.65 | 3.04 | 2.80 | 2.21 | 0.00 |
| Earning Retention Ratio (%) | 93.97 | 94.95 | 96.70 | 97.21 | 0.00 |
| Cash Earning Retention Ratio (%) | 96.35 | 96.96 | 97.20 | 97.79 | 0.00 |
| Interest Coverage Ratio (X) | 8.26 | 7.62 | 18.30 | 16.95 | 7.08 |
| Interest Coverage Ratio (Post Tax) (X) | 4.71 | 4.27 | 12.33 | 10.90 | -0.96 |
| Enterprise Value (Cr.) | 46006.81 | 35822.28 | 34443.07 | 31565.58 | 7693.95 |
| EV / Net Operating Revenue (X) | 9.71 | 8.37 | 6.06 | 7.98 | 2.90 |
| EV / EBITDA (X) | 37.88 | 35.32 | 16.11 | 23.75 | 9.65 |
| MarketCap / Net Operating Revenue (X) | 9.33 | 7.95 | 5.83 | 7.64 | 2.38 |
| Retention Ratios (%) | 93.96 | 94.94 | 96.69 | 97.20 | 0.00 |
| Price / BV (X) | 6.09 | 5.73 | 6.00 | 7.10 | 1.81 |
| Price / Net Operating Revenue (X) | 9.33 | 7.95 | 5.83 | 7.64 | 2.38 |
| EarningsYield | 0.01 | 0.01 | 0.04 | 0.02 | -0.03 |
After reviewing the key financial ratios for Gujarat Fluorochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 49.70. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.70, marking an increase of 10.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 49.70. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.70, marking an increase of 10.10.
- For Cash EPS (Rs.), as of Mar 25, the value is 81.95. This value is within the healthy range. It has increased from 65.64 (Mar 24) to 81.95, marking an increase of 16.31.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 659.93. It has increased from 540.40 (Mar 24) to 659.93, marking an increase of 119.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 659.93. It has increased from 540.40 (Mar 24) to 659.93, marking an increase of 119.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 431.07. It has increased from 389.70 (Mar 24) to 431.07, marking an increase of 41.37.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 110.52. This value is within the healthy range. It has increased from 92.33 (Mar 24) to 110.52, marking an increase of 18.19.
- For PBIT / Share (Rs.), as of Mar 25, the value is 78.25. This value is within the healthy range. It has increased from 66.29 (Mar 24) to 78.25, marking an increase of 11.96.
- For PBT / Share (Rs.), as of Mar 25, the value is 64.87. This value is within the healthy range. It has increased from 54.17 (Mar 24) to 64.87, marking an increase of 10.70.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 49.68. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.68, marking an increase of 10.08.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 49.69. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.69, marking an increase of 10.09.
- For PBDIT Margin (%), as of Mar 25, the value is 25.63. This value is within the healthy range. It has increased from 23.69 (Mar 24) to 25.63, marking an increase of 1.94.
- For PBIT Margin (%), as of Mar 25, the value is 18.15. This value is within the healthy range. It has increased from 17.01 (Mar 24) to 18.15, marking an increase of 1.14.
- For PBT Margin (%), as of Mar 25, the value is 15.04. This value is within the healthy range. It has increased from 13.90 (Mar 24) to 15.04, marking an increase of 1.14.
- For Net Profit Margin (%), as of Mar 25, the value is 11.52. This value exceeds the healthy maximum of 10. It has increased from 10.16 (Mar 24) to 11.52, marking an increase of 1.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.52. This value is within the healthy range. It has increased from 10.16 (Mar 24) to 11.52, marking an increase of 1.36.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.52. This value is below the healthy minimum of 15. It has increased from 7.32 (Mar 24) to 7.52, marking an increase of 0.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.63. This value is within the healthy range. It has decreased from 10.81 (Mar 24) to 10.63, marking a decrease of 0.18.
- For Return On Assets (%), as of Mar 25, the value is 5.14. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 5.14, marking an increase of 0.43.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.27, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 0.48 (Mar 24) to 0.47, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.36 (Mar 24) to 1.70, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 24) to 0.97, marking an increase of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 4. It has increased from 1.52 (Mar 24) to 2.79, marking an increase of 1.27.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.03. This value is below the healthy minimum of 20. It has increased from 5.05 (Mar 24) to 6.03, marking an increase of 0.98.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 20. It has increased from 3.04 (Mar 24) to 3.65, marking an increase of 0.61.
- For Earning Retention Ratio (%), as of Mar 25, the value is 93.97. This value exceeds the healthy maximum of 70. It has decreased from 94.95 (Mar 24) to 93.97, marking a decrease of 0.98.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.35. This value exceeds the healthy maximum of 70. It has decreased from 96.96 (Mar 24) to 96.35, marking a decrease of 0.61.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.26. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 8.26, marking an increase of 0.64.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.71. This value is within the healthy range. It has increased from 4.27 (Mar 24) to 4.71, marking an increase of 0.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 46,006.81. It has increased from 35,822.28 (Mar 24) to 46,006.81, marking an increase of 10,184.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.71. This value exceeds the healthy maximum of 3. It has increased from 8.37 (Mar 24) to 9.71, marking an increase of 1.34.
- For EV / EBITDA (X), as of Mar 25, the value is 37.88. This value exceeds the healthy maximum of 15. It has increased from 35.32 (Mar 24) to 37.88, marking an increase of 2.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 3. It has increased from 7.95 (Mar 24) to 9.33, marking an increase of 1.38.
- For Retention Ratios (%), as of Mar 25, the value is 93.96. This value exceeds the healthy maximum of 70. It has decreased from 94.94 (Mar 24) to 93.96, marking a decrease of 0.98.
- For Price / BV (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 3. It has increased from 5.73 (Mar 24) to 6.09, marking an increase of 0.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 3. It has increased from 7.95 (Mar 24) to 9.33, marking an increase of 1.38.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Fluorochemicals Ltd:
- Net Profit Margin: 11.52%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.63% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.52% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.97
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 55.6 (Industry average Stock P/E: 65.35)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.52%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Plot No. 1, Khasra Nos. 264 to 267, UNA Gujarat 174303 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Devendra Kumar Jain | Chairman & Non Independent Director |
| Mr. Vivek Kumar Jain | Mng.Director&Non Ind.Director |
| Dr. Bir Kapoor | Deputy Managing Director |
| Mr. Sunil Kumar Singh Chahuan | Whole Time & Non-Independent Director |
| Mr. Shanti Prashad Jain | Independent Director |
| Mr. Shailendra Swarup | Independent Director |
| Mr. Om Prakash Lohia | Independent Director |
| Mr. Chandra Prakash Jain | Independent Director |
| Ms. Vanita Bhargava | Independent Director |
FAQ
What is the intrinsic value of Gujarat Fluorochemicals Ltd?
Gujarat Fluorochemicals Ltd's intrinsic value (as of 09 January 2026) is ₹2557.66 which is 25.74% lower the current market price of ₹3,444.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹37,833 Cr. market cap, FY2025-2026 high/low of ₹4,098/3,100, reserves of ₹7,606 Cr, and liabilities of ₹10,618 Cr.
What is the Market Cap of Gujarat Fluorochemicals Ltd?
The Market Cap of Gujarat Fluorochemicals Ltd is 37,833 Cr..
What is the current Stock Price of Gujarat Fluorochemicals Ltd as on 09 January 2026?
The current stock price of Gujarat Fluorochemicals Ltd as on 09 January 2026 is ₹3,444.
What is the High / Low of Gujarat Fluorochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Fluorochemicals Ltd stocks is ₹4,098/3,100.
What is the Stock P/E of Gujarat Fluorochemicals Ltd?
The Stock P/E of Gujarat Fluorochemicals Ltd is 55.6.
What is the Book Value of Gujarat Fluorochemicals Ltd?
The Book Value of Gujarat Fluorochemicals Ltd is 693.
What is the Dividend Yield of Gujarat Fluorochemicals Ltd?
The Dividend Yield of Gujarat Fluorochemicals Ltd is 0.09 %.
What is the ROCE of Gujarat Fluorochemicals Ltd?
The ROCE of Gujarat Fluorochemicals Ltd is 9.89 %.
What is the ROE of Gujarat Fluorochemicals Ltd?
The ROE of Gujarat Fluorochemicals Ltd is 8.29 %.
What is the Face Value of Gujarat Fluorochemicals Ltd?
The Face Value of Gujarat Fluorochemicals Ltd is 1.00.